Cite

HARVARD Citation

    Angelergues, A. et al. (n.d.). 2538 Response to cabazitaxel in patients with metastatic castrationresistant prostate cancer (mCRPC) poorly responding to docetaxel. European journal of cancer. pp. S488-. [Online]. 
  
Back to record